News Release
RICHMOND, Va., Nov. 5 /PRNewswire-FirstCall/ -- Tredegar Corporation (NYSE: TG) reported a third-quarter net loss of $18.4 million (47 cents per share) compared to net income of $9.7 million (25 cents per share) in the third quarter of 2006. Earnings from manufacturing operations in the third quarter were $7.9 million (20 cents per share) versus $10.0 million (26 cents per share) last year. Third-quarter sales decreased to $275.7 million from $296.3 million in 2006. A summary of results for the third quarter and first nine months of 2007 and 2006 is shown below:
(In Millions, Except Per-Share Data)
Three Months Ended Nine Months Ended
September 30 September 30
2007 2006 2007 2006
Sales $275.7 $296.3 $836.9 $846.7
Net income (loss) as reported
under generally accepted
accounting principles (GAAP) $(18.4) $9.7 $1.9 $27.2
After-tax effects of:
Loss associated with plant
shutdowns, asset impairments
and restructurings:
Asset impairment relating to
aluminum extrusion operations
in Canada 22.7 - 22.7 -
Other 3.6 1.0 4.2 2.9
(Gains) losses from sale of assets
and other items - (.7) (.7) (1.6)
Income from manufacturing operations* 7.9 $10.0 $28.1 $28.5
Diluted earnings (loss) per share
as reported under GAAP $(.47) $.25 $.05 $.70
After-tax effects per diluted
share of:
Loss associated with plant
shutdowns, asset impairments
and restructurings:
Asset impairment relating to
aluminum extrusion operations
in Canada .58 - .58 -
Other .09 .03 .10 .07
(Gains) losses from sale of assets
and other items - (.02) (.02) (.04)
Diluted earnings per share from
manufacturing operations* $.20 $.26 $.71 $.73
* The after-tax effects of unusual items, plant shutdowns, asset
impairments and restructurings, and gains or losses from sale of assets
and other items have been presented separately and removed from net
income and earnings per share as reported under GAAP to determine
Tredegar's presentation of income and earnings per share from
manufacturing operations. Income and earnings per share from
manufacturing operations are key financial and analytical measures used
by Tredegar to gauge the operating performance of its manufacturing
businesses. They are not intended to represent the stand-alone results
for Tredegar's manufacturing businesses under GAAP and should not be
considered as an alternative to net income or earnings per share as
defined by GAAP. They exclude items that we believe do not relate to
Tredegar's ongoing manufacturing operations.
John D. Gottwald, Tredegar's president and chief executive officer, said: "Our overall loss for the quarter was due to an after-tax asset impairment charge of $22.7 million or 58 cents per share relating to our aluminum extrusions operations in Canada, which had an operating loss of $7 million or 12 cents per share after taxes in the first nine months of 2007. Earnings from manufacturing operations excluding special items declined by 6 cents per share or 23% in the third quarter of 2007 versus last year due to lower operating profits in aluminum extrusions and a higher effective tax rate, partially offset by higher profits in films and lower pension and interest costs. Profit growth in films during the third quarter of 2007 versus last year was driven by appreciation of currencies for operations outside of the U.S. and increases in sales of high-value materials used primarily for the hygiene market. Results in films continue to fluctuate significantly from quarter-to-quarter."
Mr. Gottwald continued: "Business conditions in aluminum continue to be challenging. Operating profit in the third quarter declined primarily due to lower volume in the U.S. and Canada. Demand for extruded aluminum shapes is down significantly in most market segments. Our bookings and backlog continue to be at seasonally adjusted lows. In Canada, the combination of lower volume and appreciation of the Canadian dollar, which impacts our costs, has caused a shift from overall profitability last year to losses this year. We are very focused on addressing our issues in Canada."
Mr. Gottwald further stated: "During the third quarter of 2007 we used a portion of a standing authorization from our Board of Directors to repurchase approximately 1.7 million shares of our stock at an average price of $17.14 per share. Despite the significant funds used for this program, our net debt at September 30, 2007 was $5.2 million, a decrease of $16.4 million since the beginning of the year due to strong cash flow from operations."
MANUFACTURING OPERATIONS
Film Products
Third-quarter net sales in Film Products were $134.1 million, down slightly from $135.0 million in the third quarter of 2006, while operating profit from ongoing operations increased to $15.9 million in the third quarter of 2007 from $13.8 million in 2006. Volume was 60.0 million pounds in the third quarter of 2007 compared with 64.3 million pounds in the third quarter of last year.
Volume was down in the third quarter of 2007 compared with the third quarter of 2006 primarily due to a decrease in sales of lower margin packaging and barrier films, partially offset by an increase in sales of high-value materials used primarily for the hygiene market. Net sales declined for the same reasons but were partially offset by appreciation of currencies for operations outside of the U.S.
Operating profit from ongoing operations increased in the third quarter of 2007 compared with the third quarter of 2006 due primarily to appreciation of currencies for operations outside of the U.S. (a benefit of approximately $900,000) and increases in sales of the high-value materials noted above, partially offset by lower volume and margins for packaging and barrier films. The company estimates that the impact of the lag in the pass-through of changes in average resin costs had a negative impact on operating profit of approximately $1 million in the third quarter of 2007 compared with an estimated negative impact on operating profit of $1.5 million in the third quarter of 2006. Film Products has index-based pass-through raw material cost agreements for the majority of its business. However, under certain agreements, changes in resin prices are not passed through for an average period of 90 days.
Net sales in Film Products were $400.4 million in the first nine months of 2007, up 4.6% versus $382.7 million in the first nine months of 2006. Operating profit from ongoing operations was $46.5 million in the first nine months of 2007, up 9.2% compared with $42.6 million in the first nine months of 2006. Volume decreased to 185.7 million pounds in the first nine months of 2007 from 190.8 million pounds in the first nine months of 2006. The growth in sales and operating profit during the first nine months of 2007 versus 2006 were primarily due to increases in sales of high-value surface protection and hygiene materials and appreciation of currencies for operations outside of the U.S. (currency appreciation resulted in an improvement in operating profit of approximately $2.1 million), partially offset by lower volume and margins for packaging and barrier films. Volume declined primarily due to lower sales of certain commodity barrier films that were dropped in conjunction with the shutdown in the second quarter of 2006 of the plant in LaGrange, Georgia.
Capital expenditures were $11.7 million in the first nine months of 2007 and are projected to be approximately $20 million for the year. Depreciation expense was $25 million in the first nine months of 2007 and is projected to be $33 million for the year.
Aluminum Extrusions
Third-quarter net sales in Aluminum Extrusions were $135.2 million, down 12.2% from $154.0 million in the third quarter of 2006. Operating profit from ongoing operations decreased to $1.1 million in the third quarter of 2007, down 80% from $5.4 million in the third quarter of 2006. Volume decreased to 55.9 million pounds in the third quarter of 2007, down 18.3% from 68.4 million pounds in the third quarter of 2006.
Net sales in Aluminum Extrusions were $417.4 million in the first nine months of 2007, down 5.8% from $443.0 million in the first nine months of 2006. Operating profit from ongoing operations decreased to $7.9 million in the first nine months of 2007, down 50.3% from $15.9 million in the first nine months of 2006. Volume decreased to 170.6 million pounds in the first nine months of 2007, down 15.3% from 201.5 million pounds in the first nine months of 2006.
The decreases in net sales and operating profit in the third quarter and first nine months were mainly due to lower volume partially offset by higher selling prices. Appreciation of the Canadian Dollar also had an estimated adverse impact on operating profit of $600,000 in the third quarter of 2007 versus 2006 and $1.3 million in the first nine months of 2007 versus 2006. Shipments declined in most markets, especially extrusions used in hurricane protection products and residential construction. Overall backlog at the end of the quarter was 14.9 million pounds, down from 25.4 million pounds at September 30, 2006.
Capital expenditures were $4.2 million in the first nine months of 2007 and are projected to be approximately $6 million for the year. Depreciation expense was $9.4 million in the first nine months of 2007 and is projected to be $13 million for the year.
During the third quarter of 2007, as a result of deteriorating business conditions and financial results relating to aluminum extrusions operations in Canada, Tredegar recognized an asset impairment charge of $27.6 million ($22.7 million or 58 cents per share after taxes). After this charge the carrying value of the business unit's net assets (assets in excess of liabilities excluding cash and deferred income taxes) were approximately $43 million. During the first nine months of 2007, the aluminum extrusions business in Canada had volume of 46.9 million pounds, net sales of $119.1 million, an operating loss of $7 million, depreciation of $3 million and capital expenditures of $734,000. During the first nine months of 2006, this business had volume of 57 million pounds, net sales of $132.1 million, operating profit of $981,000, depreciation of $2.9 million and capital expenditures of $672,000.
OTHER ITEMS
Net pension income was $536,000 in the third quarter of 2007 and $1.7 million in the first nine months of 2007, a favorable change of $1.1 million (2 cents per share after taxes) and $3.6 million (6 cents per share after taxes) from amounts recognized in the third quarter and first nine months of 2006, respectively. Most of the favorable changes relate to a pension plan that is reflected in "Corporate expenses, net" in the operating profit by segment table. The company contributed $1.1 million to its pension plans in 2006 and expects to contribute the same amount in 2007.
Interest expense was $628,000 in the third quarter of 2007 and $2.0 million in first nine months of 2007, a decline of $703,000 (1 cent per share after taxes) and $2.2 million (4 cents per share after taxes) versus the third quarter and first nine months of last year, respectively, due to lower average debt outstanding.
The effective tax rate used to compute income from manufacturing operations was 44.2% in the third quarter of 2007 and 37.9% in the first nine months of 2007, compared with 32.7% in the third quarter of 2006 and 36.0% in the first nine months of 2006. The increase in the effective tax rate for manufacturing operations during the third quarter of 2007 versus last year, which had an unfavorable impact of approximately 4 cents per share, was mainly due to the adjustment of income taxes during the third quarter to the rate that results in a year-to-date effective tax rate that is equal to the rate estimated for the entire year. The increase in the effective tax rate for manufacturing operations for the first nine months of 2007 versus last year, which had an unfavorable impact of approximately 2 cents per share, was mainly due to (i) lower income tax benefits expected for the Domestic Production Activities Deduction and the research & development tax credit and (ii) differences in income taxes accrued on operations outside of the U.S.
During the first quarter of 2007, the company adopted new accounting standards for maintenance costs and uncertain income tax positions, neither of which had a material impact on Tredegar's results of operations or financial condition. In addition, Tredegar adopted new accounting standards on fair value measurements and the fair value option for financial assets and liabilities, neither of which had an impact on historical results at the date of adoption.
Overall results for the quarter include other special items in addition to the asset impairment charge of $22.7 million (58 cents per share) previously described relating to the aluminum extrusions operations in Canada. During the third quarter of 2007, Tredegar recognized charges of $2.1 million to writedown an investment (5 cents per share) and $312,000 (1 cent per share) for the reversal of deferred income tax assets previously recognized on prior write-downs of the investment due to uncertainty of realization. Other after- tax charges for plant shutdowns, asset impairments and restructurings were 3 cents and 4 cents per share in the third quarter and first nine months of 2007, respectively. After-tax charges for plant shutdowns, asset impairments and restructurings were 3 cents and 7 cents per share in the third quarter and first nine months of 2006, respectively. In addition, the results for the first nine months of 2007 include after-tax income of $683,000 (2 cents per share) resulting from an adjustment of deferred income taxes for a reduction in statutory income tax rates in Canada (reflected as a credit to income tax expense). Results for the third quarter and first nine months of 2006 include after-tax income of $734,000 (2 cents per share) and $1.6 million (4 cents per share) for liquidation of inventories from the shutdown of the films plant in LaGrange, Georgia that were accounted for on the last-in, first-out ("LIFO") method. Further details regarding these items are provided in the financial tables included with this press release.
As discussed in last quarter's press release, on April 2, 2007 Tredegar invested $10 million in Harbinger Capital Partners Special Situations Fund, L.P. ("Harbinger"). At September 30, 2007, Harbinger reported Tredegar's capital account value at $17.8 million reflecting $7.8 million of unrealized appreciation ($5.1 million or 13 cents per share after taxes) versus the carrying value in Tredegar's balance sheet of $10 million.
On August 31, 2007, Tredegar invested $6.5 million in a privately held drug delivery company representing ownership on a fully diluted basis of approximately 23%. This company is developing and commercializing state of the art drug delivery systems designed to improve patient compliance and outcomes. During the first nine months of 2007, Tredegar invested $5.7 million in real estate. At September 30, 2007, the carrying value in Tredegar's balance sheet of its investments in this real estate and the drug delivery company equaled the respective amounts invested.
CAPITAL STRUCTURE AND ADJUSTED EBITDA
Net debt (debt in excess of cash) was $5.2 million at September 30, 2007, compared with net debt of $21.6 million at December 31, 2006. Adjusted EBITDA from manufacturing operations, a key valuation and borrowing capacity measure, was $110.4 million for the last twelve months ended September 30, 2007. See notes to financial statements and tables for reconciliations to comparable GAAP measures.
During the third quarter of 2007, Tredegar used a portion of a standing authorization from its Board of Directors to repurchase approximately 1.7 million shares of its stock at an average price of $17.14 per share. As of September 30, 2007, the company had approximately 3.3 million shares that can be repurchased in the future under this authorization.
FORWARD-LOOKING AND CAUTIONARY STATEMENTS
Some of the information contained in this press release may constitute "forward-looking statements" within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. When we use the words "believe," "estimate," "anticipate," "expect," "project," "likely," "may" and similar expressions, we do so to identify forward-looking statements. Such statements are based on our then current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those addressed in the forward-looking statements. It is possible that our actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements. Factors that could cause actual results to differ from expectations include, without limitation: Film Products is highly dependent on sales to one customer - The Procter & Gamble Company; growth of Film Products depends on its ability to develop and deliver new products at competitive prices; sales volume and profitability of Aluminum Extrusions is cyclical and highly dependent on economic conditions of end-use markets in the United States and Canada, particularly in the construction, distribution and transportation industries and are also subject to seasonal slowdowns; our substantial international operations subject us to risks of doing business in foreign countries, which could adversely affect our business, financial condition and results of operations; our future performance is influenced by costs incurred by our operating companies including, for example, the cost of energy and raw materials; and the factors discussed in the reports Tredegar files with or furnishes to the Securities and Exchange Commission (the "SEC") from time-to-time, including the risks and important factors set forth in "Risk Factors" in Part I, Item 1A of our 2006 Annual Report on Form 10-K and our Quarterly Report on Form 10-Q for this period that will be filed with the SEC.
Tredegar does not undertake to update any forward-looking statement made in this press release to reflect any change in management's expectations or any change in conditions, assumptions or circumstances on which such statements are based.
To the extent that the financial information portion of this release contains non-GAAP financial measures, it also presents both the most directly comparable financial measures calculated and presented in accordance with GAAP and a quantitative reconciliation of the difference between any such non-GAAP measures and such comparable GAAP financial measures. Accompanying the reconciliation is management's statement concerning the reasons why management believes that presentation of non-GAAP measures provides useful information to investors concerning Tredegar's financial condition and results of operations.
Based in Richmond, Va., Tredegar Corporation is a global manufacturer of plastic films and aluminum extrusions.
Tredegar Corporation
Condensed Consolidated Statements of Income
(In Thousands, Except Per-Share Data)
(Unaudited)
Third Quarter Ended Nine Months Ended
September 30 September 30
2007 2006 2007 2006
Sales $275,726 $296,256 $836,902 $846,711
Other income (expense),
net (a) (b) (1,987) 474 (1,533) 734
273,739 296,730 835,369 847,445
Cost of goods sold (a) 234,314 252,848 712,236 719,177
Freight 6,477 7,265 19,100 20,989
Selling, R&D and general
expenses 20,173 20,151 58,724 56,684
Amortization of intangibles 37 37 112 112
Interest expense 628 1,331 2,009 4,231
Asset impairments and costs
associated with exit and
disposal activities (a) 29,324 692 30,182 3,410
290,953 282,324 822,363 804,603
Income (loss) before income
taxes (17,214) 14,406 13,006 42,842
Income taxes (b) 1,162 4,716 11,114 15,687
Net income (loss) (a) (b) (c) $(18,376) $9,690 $1,892 $27,155
Earnings (loss) per share:
Basic $(.47) $.25 $.05 $.70
Diluted (.47) .25 .05 .70
Shares used to compute earnings
(loss) per share:
Basic 38,985 38,654 39,219 38,629
Diluted 38,985 39,123 39,396 38,876
Tredegar Corporation
Net Sales and Operating Profit by Segment
(In Thousands)
(Unaudited)
Third Quarter Ended Nine Months Ended
September 30 September 30
2007 2006 2007 2006
Net Sales
Film Products $134,065 $134,961 $400,385 $382,697
Aluminum Extrusions 135,184 154,030 417,417 443,025
Total net sales 269,249 288,991 817,802 825,722
Add back freight 6,477 7,265 19,100 20,989
Sales as shown in the
Consolidated Statements
of Income $275,726 $296,256 $836,902 $846,711
Operating Profit
Film Products:
Ongoing operations $15,926 $13,770 $46,508 $42,611
Plant shutdowns, asset
impairments and
restructurings, net of gains
on sale of assets and
related income from LIFO
inventory liquidations (a) - 1,022 (393) 207
Aluminum Extrusions:
Ongoing operations 1,131 5,407 7,885 15,947
Plant shutdowns, asset
impairments and
restructurings (a) (28,146) (920) (28,245) (1,434)
AFBS (d):
Loss on investment in Therics,
LLC - - - (25)
Plant shutdowns, asset
impairments and
restructurings (a) (1,220) (494) (1,586) (494)
Total (12,309) 18,785 24,169 56,812
Interest income 289 315 960 822
Interest expense 628 1,331 2,009 4,231
Gain on the sale of corporate
assets (b) - - - 56
Loss from write-down of an
investment (b) 2,095 - 2,095 -
Stock option-based compensation
costs (e) 236 215 701 708
Corporate expenses, net 2,235 3,148 7,318 9,909
Income (loss) before income
taxes (17,214) 14,406 13,006 42,842
Income taxes (b) 1,162 4,716 11,114 15,687
Net income (loss) (a) (b) (c) $(18,376) $9,690 $1,892 $27,155
Tredegar Corporation
Condensed Consolidated Balance Sheets
(In Thousands)
(Unaudited)
September December
30, 2007 31, 2006
Assets
Cash & cash equivalents $38,946 $40,898
Accounts & notes receivable, net 143,689 121,834
Income taxes recoverable 4,003 10,975
Inventories 64,890 68,930
Deferred income taxes 7,693 6,055
Prepaid expenses & other 3,801 4,558
Total current assets 263,022 253,250
Property, plant & equipment, net 288,680 325,763
Other assets (f) 87,556 64,078
Goodwill & other intangibles 141,848 138,696
Total assets $781,106 $781,787
Liabilities and Shareholders' Equity
Accounts payable $94,120 $69,426
Accrued expenses 39,431 41,906
Current portion of long-term debt 638 678
Total current liabilities 134,189 112,010
Long-term debt 43,515 61,842
Deferred income taxes 78,784 75,772
Other noncurrent liabilities (f) 17,237 15,568
Shareholders' equity (f) 507,381 516,595
Total liabilities and shareholders' equity $781,106 $781,787
Tredegar Corporation
Condensed Consolidated Statement of Cash Flows
(In Thousands)
(Unaudited)
Nine Months Ended
September 30
2007 2006
Cash flows from operating
activities:
Net income (loss) $1,892 $27,155
Adjustments for noncash items:
Depreciation 34,440 32,619
Amortization of intangibles 112 112
Deferred income taxes (6,691) 10,135
Accrued pension income and postretirement
benefits (1,297) 2,358
Gain on sale of assets - (56)
Loss on asset impairments and divestitures 29,983 1,150
Changes in assets and liabilities, net of effects
of acquisitions and divestitures:
Accounts and notes receivables (15,880) (37,600)
Inventories 8,868 5,180
Income taxes recoverable 6,972 2,353
Prepaid expenses and other 886 870
Accounts payable 18,124 25,109
Accrued expenses (3,333) 7,877
Other, net 314 (938)
Net cash provided by operating activities 74,390 76,324
Cash flows from investing activities:
Capital expenditures (15,919) (31,714)
Investments, including Harbinger ($10 million),
a drug delivery company ($6.5 million) and
real estate ($5.7 million) in 2007 (22,631) (542)
Proceeds from the sale of assets and property
disposals & reimbursements from customers for
purchases of equipment 4,093 266
Net cash used in investing activities (34,457) (31,990)
Cash flows from financing activities:
Dividends paid (4,701) (4,656)
Debt principal payments (33,367) (38,956)
Borrowings 15,000 4,000
Repurchases of Tredegar common stock,
net of settlement payable of $2,307 (26,705) -
Proceeds from exercise of stock options 6,470 1,162
Net cash used in financing activities (43,303) (38,450)
Effect of exchange rate changes on cash 1,418 524
(Decrease) increase in cash and cash equivalents (1,952) 6,408
Cash and cash equivalents at beginning of period 40,898 23,434
Cash and cash equivalents at end of period $38,946 $29,842
Selected Financial Measures
(In Millions)
(Unaudited)
For the Twelve Months Ended
September 30, 2007
Film Aluminum
Products Extrusions Total
Operating profit from ongoing operations $61.5 $14.0 $75.5
Allocation of corporate overhead (8.6) (2.5) (11.1)
Add back depreciation and amortization 33.3 12.7 46.0
Adjusted EBITDA (g) $86.2 $24.2 $110.4
Selected balance sheet and other data as
of September 30, 2007:
Net debt (cash) (h) $5.2
Shares outstanding 37.9
Notes to the Financial Tables
(a) Plant shutdowns, asset impairments and restructurings in the third
quarter of 2007 include:
-- A pretax charge of $27.6 million for impairments of property, plant
and equipment related to the aluminum extrusions operations in
Canada;
-- A pretax charge of $1.2 million related to the estimated loss on
the sub-lease of a portion of the AFBS (formerly Therics) facility
in Princeton, New Jersey;
-- A pretax charge of $493,000 for severance and other employee-
related costs in Aluminum Extrusions; and
-- A pretax charge of $42,000 related to expected future environmental
costs at the aluminum extrusions facility in Newnan, Georgia
(included in "Cost of goods sold" in the condensed consolidated
statements of income).
Plant shutdowns, asset impairments and restructurings in the first
nine months of 2007 include:
-- A pretax charge of $27.6 million for impairments of property, plant
and equipment related to the aluminum extrusions operations in
Canada;
-- A pretax charge of $1.6 million related to the estimated loss on
the sub-lease of a portion of the AFBS (formerly Therics) facility
in Princeton, New Jersey;
-- A pretax charge of $592,000 for severance and other employee-
related costs in Aluminum Extrusions;
-- Pretax charges of $338,000 for asset impairments in Film Products;
-- A pretax charge of $55,000 for costs related to the shutdown of the
films manufacturing facility in LaGrange, Georgia; and
-- A pretax charge of $42,000 related to expected future environmental
costs at the aluminum extrusions facility in Newnan, Georgia
(included in "Cost of goods sold" in the condensed consolidated
statements of income).
Plant shutdowns, asset impairments and restructurings in the third
quarter of 2006 include:
-- A net pretax gain of $1 million associated with the shutdown of the
films manufacturing facility in LaGrange, Georgia, including a gain
of $1.2 million for related LIFO inventory liquidations (included
in "Cost of goods sold" in the condensed consolidated statements of
income), partially offset by other shutdown-related costs of
$198,000;
-- A pretax charge of $920,000 related to expected future
environmental costs at the aluminum extrusions facility in Newnan,
Georgia (included in "Cost of goods sold" in the condensed
consolidated statements of income); and
-- A pretax charge of $494,000 related to the estimated loss on the
sub-lease of a portion of the AFBS (formerly Therics) facility in
Princeton, New Jersey.
Plant shutdowns, asset impairments and restructurings in the first
nine months of 2006 include:
-- A net pretax gain of $1.4 million associated with the shutdown of
the films manufacturing facility in LaGrange, Georgia, including a
gain of $2.6 million for related LIFO inventory liquidations
(included in "Cost of goods sold" in the condensed
consolidated statements of income), partially offset by severance
and other costs of $1 million and asset impairment charges of
$130,000;
-- Pretax charges of $1 million for asset impairments in Film
Products;
-- A pretax charge of $920,000 related to expected future
environmental costs at the aluminum extrusions facility in Newnan,
Georgia (included in "Cost of goods sold" in the condensed
consolidated statements of income);
-- Pretax charges of $727,000 for severance and other employee-related
costs in connection with restructurings in Film Products ($213,000)
and Aluminum Extrusions ($514,000); and
-- A pretax charge of $494,000 related to the estimated loss on the
sub-lease of a portion of the AFBS (formerly Therics) facility in
Princeton, New Jersey.
(b) Gain on the sale of corporate assets in 2006 includes a gain related
to the sale of public equity securities.
The loss from the write-down of an investment of $2.1 million is
included in "Other income (expense), net" in the condensed
consolidated statements of income.
Income taxes in 2007 include the recognition of a valuation allowance
of $1.1 million in the third quarter for expected limitations on the
utilization of assumed capital losses on certain investments and a tax
benefit of $682,000 recorded in the second quarter related to an
adjustment to deferred income taxes for a reduction in statutory
income tax rates in Canada.
(c) Comprehensive income (loss), defined as net income and other
comprehensive income (loss), was a loss of $12.2 million for the third
quarter of 2007 and income of $11.9 million for the third quarter
of 2006. Comprehensive income (loss) was income of $17 million for the
first nine months of 2007 and income of $32.2 million for the first
nine months of 2006. Other comprehensive income (loss) includes
changes in unrealized gains and losses on available-for-sale
securities, foreign currency translation adjustments, unrealized gains
and losses on derivative financial instruments and amortization of
prior service cost and net gains or losses from pension and other
postretirement benefit plans recorded net of deferred taxes directly
in shareholders' equity.
(d) On June 30, 2005, substantially all of the assets of AFBS, Inc.
(formerly Therics, Inc.), a wholly-owned subsidiary of Tredegar, were
sold or assigned to a newly-created limited liability company,
Therics, LLC, controlled and managed by an individual not affiliated
with Tredegar. AFBS retained substantially all of its liabilities in
the transaction, which included customary indemnification
provisions for pre-transaction liabilities. AFBS received a 17.5%
equity interest in the new company valued at $170,000 and a 3.5%
interest in Theken Spine, LLC valued at $800,000, along with potential
future payments on the sale of certain products by Therics, LLC.
(e) Effective January 1, 2006, Tredegar adopted Statement of Financial
Accounting Standards (SFAS) No. 123( R ), "Share-Based Payment" (SFAS
123( R )) using the modified prospective method. SFAS 123( R )
requires the company to record compensation expense for all share-
based awards. Tredegar previously applied Accounting Principles Board
(APB) Opinion No. 25, "Accounting for Stock Issued to Employees," and
related interpretations and provided the required pro forma
disclosures of SFAS No. 123, "Accounting for Stock-Based Compensation"
(SFAS 123). Prior periods were not restated.
(f) Effective December 31, 2006, Tredegar adopted SFAS No. 158,
"Employers' Accounting for Defined Benefit Pension and Other
Postretirement Plans" (SFAS 158). This statement requires the
recognition in the balance sheet of the funded status of each of our
defined benefit pension and other postretirement plans. Each
overfunded plan is recognized as an asset and each underfunded plan is
recognized as a liability. The initial impact of SFAS 158, net of
deferred taxes, was recognized directly in shareholders' equity.
Adjustments from the new standard will not impact our debt covenant
computations since our credit agreement allows us to elect
to use generally accepted accounting principles in effect when the
agreement was signed.
(g) Adjusted EBITDA for the twelve months ended September 30, 2007,
represents income from continuing operations before interest, taxes,
depreciation, amortization, unusual items and losses associated with
plant shutdowns, asset impairments and restructurings, gains from
the sale of assets, investment write-down, charges related to stock
option awards accounted for under the fair value-based method and
other items. Adjusted EBITDA is not intended to represent cash flow
from operations as defined by GAAP and should not be considered
as either an alternative to net income (as an indicator of operating
to cash flow (as a measure of liquidity). Tredegar uses Adjusted
EBITDA as a measure of unlevered (debt-free) operating cash flow. We
also use it when comparing relative enterprise values of
manufacturing companies and when measuring debt capacity. When
comparing the valuations of a peer group of manufacturing companies,
we express enterprise value as a multiple of Adjusted EBITDA. We
believe Adjusted EBITDA is preferable to operating profit and other
GAAP measures when applying a comparable multiple approach to
enterprise valuation because it excludes the items noted above,
measures of which may vary among peer companies.
(h) Net debt is calculated as follows (in millions):
Debt $44.1
Less: Cash and cash equivalents (38.9)
Net debt $5.2
Net debt is not intended to represent total debt or debt defined by
GAAP. Net debt is utilized by management in evaluating the company's
financial leverage and equity valuation and the company believes that
investors also may find net debt to be helpful for the same purposes.
SOURCE Tredegar Corporation
CONTACT: D. Andrew Edwards of Tredegar Corporation, +1-804-330-1041,
Fax: +1-804-330-1777, daedward@tredegar.com
